Shoulder Innovations
NYSE: SINorthern California, US · Founded 2015 · Delaware corporation · 114 employees on LinkedIn · 9 known investors
Find your way into Shoulder Innovations
155 people in our graph share verified history with the Shoulder Innovations team — schools, employers, funds. One of them is your warm intro.
Elena Pantaziunlockedknows Matthew Ahearn · together at INSEAD (overlapped)
knows the team · via Cardiovascular Systems Inc
×6knows the team · via University of St. Thomas
×4knows the team · via INSEAD
Shoulder Innovations develops InSet® glenoid technology for shoulder joint implants that reduce the rocking horse effect and provide mechanical stability, serving patients with severe shoulder arthritis. The company produces medical devices for orthopedic shoulder procedures.
Founders & leadership
RB
MA
Matthew AhearninChief Operating OfficerHe has background in medical device venture capital, finance, and operations.
JP
Jeff PointsinChief Financial OfficerJeff Points is an executive with over 25 years of financial leadership experience in public life sciences companies, with expertise in corporate development, strategic transactions, and financing.
DB
David BlueinChief Customer Experience OfficerDavid Blue is Executive Officer at Shoulder Innovations, which manufactures InSet® glenoid technology for shoulder joint implants designed to reduce instability in patients with severe shoulder arthritis.
DR
Don RunningManager and Chief Executive Officer
JO
DL
David L. BlueinChief Customer Experience OfficerDavid L. Blue is Chief Customer Experience Officer at Shoulder Innovations, a developer of InSet® glenoid technology for shoulder joint implants. He has experience in medical device development, FDA regulatory processes, and commercialization within the orthopedic sector.
Board
GP
Geoff PardoBoard director
MC
CT
MD
PB
Paul BuckmanBoard director
Investors · 9
APERTURE Venture PartnersBoston · $1M – $5M
Arboretum VenturesAnn Arbor · $5M – $15M
Genesis Innovation GroupGrand Rapids
Global BrainTokyo · $100K – $184M
Invest MichiganNorthville · $100K – $250K
Lightstone VenturesPortola Valleyvia Mike Carusi · board
US Venture PartnersMenlo Park · $500K – $10Mvia Casey Tansey · board
Wakestream VenturesGrand Rapids · $150K – $500K
WMU Biosciences Research & Commercialization CenterKalamazoo · $100K – $250K
Reported raises · per SEC filings
Form D private placements$85.5M disclosed across 8 rounds · 2015–2025
▶$20.1MraisedMar 2025 · 27 investors · Other Health CareRule 506(b)
▶$20.1MraisedMar 2025 · 27 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Geoff PardoDirector
- Jeff PointsExecutive Officer
- Paul BuckmanDirector
- Mike CarusiDirector
- Kevin SidowDirector
- Matthew AhearnExecutive Officer, Director
- Casey TanseyDirector
- Robert BallExecutive Officer, Director
- David BlueExecutive Officer
- Offering amount
- $40.1M
- Amount sold
- $20.1M
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$32.2MraisedFeb 2023 · 21 investors · Other Health CareRule 506(b)
▶$32.2MraisedFeb 2023 · 21 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Casey TanseyDirector
- Mike CarusiDirector
- David BlueExecutive Officer
- Kevin SidowDirector
- Geoff PardoDirector
- Paul BuckmanDirector
- Robert BallExecutive Officer, Director
- Matthew AhearnExecutive Officer, Director
- Offering amount
- $39.8M
- Amount sold
- $32.2M
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.5MraisedOct 2022 · 5 investors · Other Health CareRule 506(b)
▶$3.5MraisedOct 2022 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robert BallExecutive Officer, Director
- Mike CarusiDirector
- David BlueExecutive Officer
- Matthew AhearnExecutive Officer, Director
- Paul BuckmanDirector
- Kevin SidowDirector
- Casey TanseyDirector
- Offering amount
- $7M
- Amount sold
- $3.5M
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$21.6MraisedOct 2020 · 24 investors · Other Health CareRule 506(b)
▶$21.6MraisedOct 2020 · 24 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Matthew AhearnExecutive Officer, Director
- Robert BallExecutive Officer, Director
- David BlueExecutive Officer
- Casey TanseyDirector
- Mike CarusiDirector
- Kevin SidowDirector
- Paul BuckmanDirector
- Offering amount
- $21.6M
- Amount sold
- $21.6M
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.2MraisedFeb 2020 · 31 investors · Other Health CareRule 506(b)
▶$2.2MraisedFeb 2020 · 31 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Matthew AhearnExecutive Officer, Director
- Robert BallExecutive Officer, Director
- Ron FrisbieDirector
- Kim PasquinoDirector
- Stephen GuntherDirector
- Offering amount
- $2.2M
- Amount sold
- $2.2M
- Minimum investment
- $1.4K
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.1MraisedNov 2018 · 27 investors · Other Health CareRule 506(b)
▶$5.1MraisedNov 2018 · 27 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Matthew AhearnExecutive Officer, Director
- Stephen GuntherDirector
- Robert BallExecutive Officer, Director
- Offering amount
- $5.6M
- Amount sold
- $5.1M
- First sale
- Feb 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$593.9KraisedMar 2016 · 4 investors · Other Health CareRule 506(b)
▶$593.9KraisedMar 2016 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Don RunningDirector
- Michael DeVriesDirector
- Stephen B GuntherDirector
- Robert BallDirector
- Offering amount
- $700K
- Amount sold
- $593.9K
- First sale
- Feb 2016
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$200KraisedMay 2015 · 1 investors · Other Health CareRule 506(b)
▶$200KraisedMay 2015 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Don RunningExecutive Officer, Director
- Jeff OndrlaExecutive Officer
- Robert BallExecutive Officer, Director
- Stephen GuntherDirector
- Michael DeVriesDirector
- Offering amount
- $200K
- Amount sold
- $200K
- Minimum investment
- $200K
- First sale
- Apr 2015
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapRead the Press Release92 shared keywordsStryker is a medical technology company that develops and manufactures products across areas such as orthopaedics, surgical equipment, neurotechnology, and spine care for hospitals and healthcare providers. It operates globally across the Americas, Europe, Asia-Pacific, and the Middle East.
Vumedi62 shared keywordsVumedi operates a peer-to-peer video education platform where clinicians watch lectures and technique videos across dozens of medical specialties. It partners with academic institutions, hospitals, and life sciences companies to provide continuing medical education content to doctors.
Doximity42 shared keywordsDoximity is the largest verified network of healthcare professionals in the U.S., connecting physicians, PAs, NPs, pharmacists, and medical students across specialties and care settings. The platform provides mobile-first tools for clinical communication, collaboration, and workflow optimization.
Companies competing with Shoulder Innovations for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Shoulder Innovations do?
- Shoulder Innovations develops InSet® glenoid technology for shoulder joint implants that reduce the rocking horse effect and provide mechanical stability, serving patients with severe shoulder arthritis. The company produces medical devices for orthopedic shoulder procedures.
- Who are Shoulder Innovations's investors?
- Shoulder Innovations's investors include APERTURE Venture Partners, Arboretum Ventures, Genesis Innovation Group, Global Brain, Invest Michigan, Lightstone Ventures, US Venture Partners, Wakestream Ventures and 1 more.
- How much funding has Shoulder Innovations raised?
- Shoulder Innovations has disclosed $85.5M raised across 8 rounds.
- Where is Shoulder Innovations headquartered?
- Shoulder Innovations is headquartered in Northern California, US.